<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical features and diagnosis of supraventricular tachycardia (SVT) in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical features and diagnosis of supraventricular tachycardia (SVT) in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical features and diagnosis of supraventricular tachycardia (SVT) in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne M Dubin, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John K Triedman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 29, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Supraventricular tachycardia (SVT) can be defined as an abnormally rapid heart rhythm originating above the ventricles, often (but not always) with a narrow QRS complex [<a href="#rid1">1</a>].</p><p>The clinical features and diagnosis of SVT will be reviewed here. The management of SVT in children is discussed separately. (See  <a class="medical medical_review" href="/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children"</a>.)</p><p>Specific types of SVT and atrial tachycardias are discussed in greater detail in separate topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/976.html" rel="external">"Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/902.html" rel="external">"Atrioventricular nodal reentrant tachycardia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14407.html" rel="external">"Atrial tachyarrhythmias in children"</a>.)</p><p></p><p class="headingAnchor" id="H152506265"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Supraventricular tachycardia (SVT) can be defined as an abnormally rapid heart rhythm originating above the ventricles, often (but not always) with a narrow QRS complex [<a href="#rid1">1</a>]. The two most common forms of SVT in children are:</p><p class="bulletIndent1"><span class="glyph">●</span>Atrioventricular reentrant tachycardia (AVRT, including the Wolff-Parkinson-White [WPW] syndrome) (see <a class="local">'AV reentrant tachycardia'</a> below), and</p><p class="bulletIndent1"><span class="glyph">●</span>Atrioventricular nodal reentrant tachycardia (AVNRT) (see <a class="local">'AV nodal reentrant tachycardia'</a> below)</p><p></p><p>Other forms of SVT include ectopic atrial tachycardia, junctional tachycardia, atrial flutter, and atrial fibrillation. For the purpose of this topic review, we will use the term "SVT" to refer only to atrioventricular (AV) reciprocating mechanisms (AVRT and AVNRT). Other narrow complex tachyarrhythmias, including primary atrial tachycardias, atrial flutter, and atrial fibrillation, are summarized in the table  (<a class="graphic graphic_table graphicRef131338" href="/d/graphic/131338.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/14407.html" rel="external">"Atrial tachyarrhythmias in children"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>SVT is the most common rhythm disturbance in children, with an estimated prevalence of 0.1 to 0.4 percent in the general pediatric population [<a href="#rid2">2</a>]. Among children with congenital heart disease (CHD), the prevalence of SVT is approximately 7 percent [<a href="#rid3">3</a>]. However, the majority of patients presenting with SVT have structurally normal hearts.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frequency of AVRT and AVNRT</strong> – The two most common forms of SVT in children are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Atrioventricular reentrant tachycardia (AVRT), including the Wolff-Parkinson-White (WPW) syndrome (see <a class="local">'AV reentrant tachycardia'</a> below)</p><p class="bulletIndent2"><span class="glyph">•</span>Atrioventricular nodal reentrant tachycardia (AVNRT) (see <a class="local">'AV nodal reentrant tachycardia'</a> below)</p><p></p><p class="bulletIndent1">In a report of 137 pediatric patients who presented with SVT and underwent electrophysiologic testing, 73 percent were found to have AVRT as the mechanism, 13 percent had AVNRT, and 14 percent had primary atrial tachycardias [<a href="#rid4">4</a>]. A similar distribution of causes was noted in another report of 346 patients (mean age 14 years) who underwent radiofrequency catheter ablation for recurrent SVT or ventricular tachycardia [<a href="#rid5">5</a>]. AVRT and AVNRT accounted for 72 and 9 percent, respectively, with various other arrhythmias comprising the remaining 19 percent.</p><p></p><p class="bulletIndent1">The relative frequencies of AVRT and AVNRT vary somewhat according to age. AVRT (including WPW) accounts for the great majority of cases in infancy (&gt;80 percent). It also is the most common category in older children, but the relative frequency is less than in infancy (50 to 60 percent) [<a href="#rid4">4,6</a>]. In contrast, AVNRT is rare before the age of two years and accounts for 20 to 35 percent of SVTs in older children [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence of preexcitation</strong> – Preexcitation refers to early activation of the ventricles due to impulses bypassing the AV node via an accessory pathway. The main electrocardiogram (ECG) findings of preexcitation include shortening of the PR interval and a delta wave  (<a class="graphic graphic_waveform graphicRef75578" href="/d/graphic/75578.html" rel="external">waveform 1</a>). This is termed the WPW pattern. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'WPW pattern on ECG'</a>.)</p><p></p><p class="bulletIndent1">The WPW pattern is estimated to occur in 0.1 to 0.25 percent of the general population [<a href="#rid7">7</a>], though it may be less frequent in young children [<a href="#rid8">8</a>]. Most asymptomatic patients with the WPW pattern on ECG remain asymptomatic. However, there is a risk of symptomatic arrhythmia, including sudden death. This is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Risk stratification of asymptomatic patients with WPW pattern'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Congenital heart disease</strong> – Although the majority of children with SVT have normally structured hearts, children with CHD have an increased risk of SVT. In one study, the reported prevalence of SVT in children with CHD was 6.5 percent [<a href="#rid3">3</a>]. CHD is more common in children with WPW syndrome than in those with AVNRT (20 to 32 versus 7 percent) [<a href="#rid5">5,9,10</a>].</p><p></p><p class="bulletIndent1">A particular association between Ebstein anomaly and AVRT has been noted; 10 to 15 percent of children with WPW have Ebstein anomaly [<a href="#rid11">11</a>], while 5 to 25 percent of children with Ebstein anomaly have WPW [<a href="#rid12">12</a>]. Ebstein anomaly is also associated with the presence of multiple accessory pathways in AVRT [<a href="#rid2">2,12</a>]. (See <a class="local">'AV reentrant tachycardia'</a> below and  <a class="medical medical_review" href="/d/html/8146.html" rel="external">"Ebstein anomaly: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H4"><span class="h1">MECHANISMS</span><span class="headingEndMark"> — </span>Most SVTs in children are reentrant rhythms. This includes atrioventricular reentrant tachycardia (AVRT, including Wolff-Parkinson-White [WPW] syndrome) and atrioventricular nodal reentrant tachycardia (AVNRT) [<a href="#rid4">4,5</a>]. A reentrant rhythm involves two distinct pathways for conduction with unidirectional block in one of the two pathways. This creates a circuit through which an electrical impulse can cycle repetitively in one direction (antegrade or retrograde), with consequent rapid, regular ventricular contractions  (<a class="graphic graphic_figure graphicRef52134" href="/d/graphic/52134.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/d/html/954.html" rel="external">"Reentry and the development of cardiac arrhythmias"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">AV reentrant tachycardia</span><span class="headingEndMark"> — </span>AVRT requires an extranodal accessory pathway connecting the atrium and ventricle. This allows direct electrical communication between the two chambers.</p><p>Accessory pathways can be located anywhere along the right and left AV groove. The most common sites are the left lateral AV groove and posteroseptal region. Right-sided pathways are less common  (<a class="graphic graphic_figure graphicRef77941" href="/d/graphic/77941.html" rel="external">figure 2</a>) [<a href="#rid13">13</a>]. The classic accessory pathway connects atrial and ventricular myocardium directly. Rarely, connections can also be made with the conducting system  (<a class="graphic graphic_figure graphicRef138850" href="/d/graphic/138850.html" rel="external">figure 3</a> and <a class="graphic graphic_table graphicRef53343" href="/d/graphic/53343.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H6"><span class="h3">Antegrade versus retrograde</span><span class="headingEndMark"> — </span>The terms "antegrade" and "retrograde" refer to the direction of electrical conduction relative to the atrium and ventricle. Accessory pathways may conduct electrical signals solely in the antegrade direction (from atrium to ventricle), solely in the retrograde direction (from ventricle to atrium), or may be capable of both antegrade and retrograde conduction.</p><p class="bulletIndent1"><span class="glyph">●</span>When the accessory pathway conducts impulses in the <strong>antegrade</strong> direction, the impulse arrives at the ventricle rapidly, without the delay imposed by the AV node, a phenomenon called "<strong>preexcitation</strong>." The result is a characteristic ECG pattern during sinus rhythm consisting of a short PR interval, a "delta wave" (both of which reflect preexcitation), and a widened QRS complex due to the delta wave  (<a class="graphic graphic_figure graphicRef75296" href="/d/graphic/75296.html" rel="external">figure 4</a>). This ECG pattern is referred to as the WPW pattern. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Electrocardiographic findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the accessory pathway conducts impulses in only the <strong>retrograde</strong> direction, it is referred to as a "<strong>concealed pathway</strong>" because the ECG during sinus rhythm appears normal. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Prevalence of concealed accessory pathways'</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Orthodromic versus antidromic</span><span class="headingEndMark"> — </span>The terms "orthodromic" and "antidromic" refer to the direction of electrical conduction through the AV node:</p><p class="bulletIndent1"><span class="glyph">●</span>The most common type of SVT is <strong>orthodromic</strong> AVRT, in which the reentrant circuit conducts impulses antegrade down the AV node through the His-Purkinje system to the ventricles and then retrograde up the accessory pathway. This results in a narrow complex tachycardia  (<a class="graphic graphic_waveform graphicRef77867" href="/d/graphic/77867.html" rel="external">waveform 2</a> and <a class="graphic graphic_figure graphicRef71302" href="/d/graphic/71302.html" rel="external">figure 5</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, <strong>antidromic</strong> AVRT is uncommon (&lt;5 percent of patients).The reentrant circuit conducts impulses antegrade down an accessory pathway (which does not involve the ventricular conducting system) and retrograde up the AV node. This causes a wide complex tachycardia because conduction through the ventricular myocardium is slower than through the conducting system  (<a class="graphic graphic_figure graphicRef50433" href="/d/graphic/50433.html" rel="external">figure 6</a> and <a class="graphic graphic_waveform graphicRef54484" href="/d/graphic/54484.html" rel="external">waveform 3</a>).</p><p></p><p class="headingAnchor" id="H8"><span class="h3">Permanent junctional reciprocating tachycardia</span><span class="headingEndMark"> — </span>Permanent junctional reciprocating tachycardia (PJRT) is a variant of orthodromic AVRT in which the retrograde conduction in the accessory pathway is slow  (<a class="graphic graphic_waveform graphicRef67767" href="/d/graphic/67767.html" rel="external">waveform 4</a>) [<a href="#rid14">14</a>]. Slow retrograde conduction through the accessory pathway coupled with the normally slow conduction antegrade through the AV node creates a stable reentrant circuit. As a result, PJRT is an incessant SVT, in contrast to the typically paroxysmal nature of most SVTs [<a href="#rid15">15</a>]. PJRT is of particular concern because its persistence can lead to tachycardia-mediated cardiomyopathy [<a href="#rid16">16</a>]. (See <a class="local">'Heart failure'</a> below.)</p><p class="headingAnchor" id="H9"><span class="h2">AV nodal reentrant tachycardia</span><span class="headingEndMark"> — </span>AVNRT is mediated by the presence, within the AV node, of two conducting pathways that are designated fast and slow. The fast pathway has a short conduction time but long refractory period. The slow pathway has a long conduction time but short refractory period. These distinct pathways allow for a reentrant loop using one pathway in the antegrade direction and one in the retrograde direction. (See  <a class="medical medical_review" href="/d/html/902.html" rel="external">"Atrioventricular nodal reentrant tachycardia"</a>.)</p><p>Typical AVNRT utilizes the slow pathway in the antegrade direction and the fast pathway in the retrograde direction  (<a class="graphic graphic_figure graphicRef79760" href="/d/graphic/79760.html" rel="external">figure 7</a> and <a class="graphic graphic_figure graphicRef50122" href="/d/graphic/50122.html" rel="external">figure 8</a>). Atypical AVNRT employs the fast pathway in the antegrade direction and the slow pathway in the retrograde direction  (<a class="graphic graphic_figure graphicRef56806" href="/d/graphic/56806.html" rel="external">figure 9</a>).</p><p>The two pathways have distinct anatomic locations. Based upon electrophysiologic (EP) studies in adult patients, the fast pathway is found in the anterior septum, while the slow pathway is recorded in the posterior septum near the mouth of the coronary sinus [<a href="#rid17">17,18</a>].</p><p>Although it has been proposed that the ability to generate AVNRT implies the presence of dual, anatomically distinct AV nodal pathways, the two pathways may not be demonstrated with EP studies. This was illustrated in a report of 159 children with AVNRT in which 38 percent did not have clear dual AV node physiology [<a href="#rid19">19</a>]. It has been suggested that, in children without dual AV node physiology, the reentry circuit may incorporate atrial muscle tissue several millimeters outside the compact AV node [<a href="#rid20">20,21</a>].</p><p class="headingAnchor" id="H10"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H11"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span>Signs and symptoms of SVT vary according to age:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants</strong> – In infants, symptoms of SVT may include pallor, fussiness, irritability, poor feeding, and/or cyanosis. The symptoms can be subtle, and tachycardia may go unrecognized for long periods of time. Because of this, infants often present with symptoms of heart failure (eg, tachypnea, fatigue with feeding, poor weight gain) [<a href="#rid22">22</a>]. (See <a class="local">'Heart failure'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children and adolescents</strong> – Common symptoms of SVT in children and adolescents include palpitations, chest discomfort, fatigue, and lightheadedness. Syncope is less common and may be a warning sign for increased risk of sudden death [<a href="#rid23">23</a>]. (See <a class="local">'Syncope and atrial fibrillation'</a> below.)</p><p></p><p>SVT is usually paroxysmal and characterized by abrupt onset and termination. Most SVT episodes occur at rest, although exercise can be a trigger in some patients.</p><p>The average duration is 10 to 15 minutes; however, some episodes last only one to two minutes, while others persist for hours [<a href="#rid2">2</a>]. More persistent SVT can occur, most commonly due to atrial tachycardias or permanent junctional reciprocating tachycardia (PJRT). (See <a class="local">'Permanent junctional reciprocating tachycardia'</a> above.)</p><p>Most children tolerate episodes of tachycardia well. However, prolonged episodes can precipitate heart failure. (See <a class="local">'Heart failure'</a> below.)</p><p>Physical examination typically reveals tachycardia without evidence of decompensation. Some patients appear pale and diaphoretic, and the blood pressure may be reduced. Infants with sustained SVT may have signs of heart failure on examination, including tachypnea, retractions, and hepatomegaly.</p><p class="headingAnchor" id="H3559732857"><span class="h2">Heart rate</span><span class="headingEndMark"> — </span>Heart rates during SVT are age dependent. Typical ranges are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Infants: 220 to 280 beats per minute (bpm)</p><p class="bulletIndent1"><span class="glyph">●</span>Children and adolescents: 180 to 240 bpm</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Heart failure</span><span class="headingEndMark"> — </span>Heart failure is not a typical feature of SVT because most episodes are paroxysmal. However, more prolonged periods of tachycardia can lead to tachycardia-induced cardiomyopathy and symptoms of heart failure. (See  <a class="medical medical_review" href="/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy"</a>.)</p><p>Heart failure most commonly occurs in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants</strong> – As previously mentioned, infants with SVT often present with signs and symptoms of heart failure because the tachycardia may go unrecognized for long periods of time. Heart failure is particularly likely when SVT persists for &gt;48 hours, whereas SVT lasting &lt;24 hours is unlikely to cause heart failure [<a href="#rid2">2</a>]. Neonates and young infants are at increased risk for heart failure due to SVT compared with older infants and children. In a study of 217 children with SVT, heart failure occurred at the first presentation in 38 percent of patients ≤4 months old compared with 19 percent of patients &gt;4 months old [<a href="#rid24">24</a>]. In another series of 109 neonates (&lt;30 days old) with SVT, 48 percent presented with clinical evidence of heart failure [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Permanent junctional reciprocating tachycardia</strong> – In contrast to the typically paroxysmal nature of most SVTs, PJRT is associated with incessant SVT, and thus affected patients are at risk of tachycardia-induced cardiomyopathy [<a href="#rid16">16</a>].</p><p></p><p>In many patients, tachycardia-induced cardiomyopathy is reversible when the arrhythmia is terminated [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Syncope and atrial fibrillation</span><span class="headingEndMark"> — </span>Syncope is an uncommon presentation of SVT. Syncope associated with Wolff-Parkinson-White (WPW) syndrome is a serious warning sign and may signal atrial fibrillation (AF) with rapid atrioventricular (AV) conduction along the accessory pathway  (<a class="graphic graphic_waveform graphicRef80996" href="/d/graphic/80996.html" rel="external">waveform 5</a>). It has been suggested that children with this presentation are at increased risk of sudden cardiac death (SCD).</p><p>In a report of 74 patients with WPW &lt;25 years old, 19 percent had a history of syncope [<a href="#rid25">25</a>]. At electrophysiologic (EP) study, nine of these patients had sustained AF compared with none of the 60 patients without syncope [<a href="#rid25">25</a>]. The patients with AF and syncope had rapid conduction down the accessory pathway as evidenced by the shortest RR interval between two consecutive preexcited QRS complexes being ≤220 msec, which, if persistent, represents a ventricular rate above 270 bpm.</p><p>In another retrospective study of children without a history of AF who had been referred for EP study and accessory pathway ablation, spontaneous degeneration to AF occurred in 27 of 53 patients in whom AV reentrant tachycardia (AVRT) was induced [<a href="#rid26">26</a>]. Rapid ventricular response was observed in 18 of these 27 patients (34 percent). (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Atrial fibrillation'</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Ventricular fibrillation and sudden death</span><span class="headingEndMark"> — </span>SCD is uncommon in patients with SVT who have structurally normal hearts. [<a href="#rid27">27</a>]. For patients who have ventricular preexcitation (ie, WPW pattern on ECG), the estimated rate of SCD is 1.1 to 1.9 per 1000 person-years [<a href="#rid23">23,28</a>]. The rate is considerably higher in children with associated heart disease (27 per 1000 person-years) [<a href="#rid23">23</a>].</p><p>Ventricular fibrillation (VF) can be the first manifestation of WPW syndrome, though this is uncommon [<a href="#rid23">23,29</a>]. VF occurring in WPW syndrome most often results from the rapid ventricular response during AF [<a href="#rid30">30</a>]. Risk factors for VF include history of AF, rapid accessory pathway conduction during AF, and multiple accessory pathways [<a href="#rid29">29-31</a>]. Studies are inconsistent as to whether the presence of symptoms correlates with increased risk of VF [<a href="#rid29">29,32,33</a>]. These risk factors for VF and SCD have been identified from case series and cohorts comprised mostly of adults with WPW. It is unclear if they are applicable to children with WPW [<a href="#rid29">29,34</a>]. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Ventricular fibrillation and sudden death'</a>.)</p><p>EP testing to evaluate accessory pathway conduction properties may help determine which children with WPW are at high risk of SCD. (See <a class="local">'Electrophysiologic evaluation'</a> below.)</p><p>In a report of 60 children who underwent EP testing prior to planned surgery for WPW, a short preexcited RR interval (&lt;220 msec) was found in all patients who were considered "high risk" (on the basis of a history of VF or resuscitated cardiac arrest) compared with 74 percent of "intermediate risk" patients (those with prior history of AF or syncope) and 35 percent of "low risk" patients (those with no history of VF, cardiac arrest, AF, or syncope) [<a href="#rid29">29</a>]. Other factors such as age, duration of symptoms, presence of congenital heart disease, presence of multiple accessory pathways, and location of accessory pathway did not differ between the three groups.</p><p>In a retrospective multicenter study of 912 children with WPW syndrome, those who experienced a life-ending or life-threatening event (sudden death [n = 6], aborted sudden death [n = 43], or AF [n = 47]) were older and less likely to have documented tachycardia compared with patients who did not (n = 816) [<a href="#rid35">35</a>]. Independent risk factors for experiencing a life-threatening event included male sex, Ebstein malformation, rapid anterograde conduction, multiple pathways, and inducible AF. However, approximately one-third of patients who experienced life-threatening events did not have prior symptoms or high-risk markers on EP testing.</p><p>The approach to risk stratification in asymptomatic patients with WPW pattern on ECG is discussed separately. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Risk stratification of asymptomatic patients with WPW pattern'</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">NATURAL HISTORY</span><span class="headingEndMark"> — </span>The natural history of SVT in childhood is related in part to the age at initial presentation and the type of rhythm disturbance.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants with AVRT</strong> – Atrioventricular reentrant tachycardia (AVRT, including Wolff-Parkinson-White [WPW] syndrome) is by far the most common mechanism of SVT in infancy, particularly during the neonatal period. For patients who present with SVT in early infancy, symptoms often resolve by one year of age, and long-term therapy may not be needed. Studies vary as to how commonly this occurs, ranging from 30 to &gt;90 percent [<a href="#rid9">9,10,36,37</a>]. Some patients who have apparent resolution of symptoms can have recurrence later in childhood [<a href="#rid9">9,36,37</a>].</p><p></p><p class="bulletIndent1">It is speculated that changes in autonomic tone during infancy and childhood may lead to this pattern of disappearance and recurrence by altering accessory pathway and AV nodal conduction and refractoriness [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children and adolescents with AVRT</strong> – SVT tends to persist in children who present with AVRT (including WPW) after the age of five years [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children and adolescents with AVNRT</strong> – Atrioventricular nodal reentrant tachycardia (AVNRT) is uncommon in early childhood. The development of AVNRT in older children may be due to maturational changes in the electrophysiologic (EP) properties of the AV node. Based on observations from EP studies, it appears that the substrate for AVNRT (dual AV node pathways, with inducible antegrade block in one limb at moderately rapid rates) is likely to be present in adolescents but not in children or infants [<a href="#rid38">38</a>].</p><p></p><p class="headingAnchor" id="H19"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3521875953"><span class="h2">Rapid hemodynamic assessment and initial management</span><span class="headingEndMark"> — </span>An infant or child who presents with a tachyarrhythmia should have an immediate hemodynamic assessment and a 15-lead ECG (12 standard leads plus leads V3R and V4R [right-sided leads analogous to V3 and V4 on the left] and V7 [left posterior axillary line at V4 level]). Continuous ECG monitoring during therapeutic maneuvers provides insight into the cause of tachycardia and helps in the planning of chronic therapy.</p><p>The most important initial clinical determination to make in children presenting with a tachyarrhythmia is whether there are signs of hemodynamic instability, including hypotension, heart failure, shock, or decreased level of consciousness. Unstable patients require immediate intervention to terminate the rhythm  (<a class="graphic graphic_table graphicRef53559" href="/d/graphic/53559.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef129940" href="/d/graphic/129940.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children", section on 'Acute management'</a>.)</p><p class="headingAnchor" id="H2035845940"><span class="h2">Referral</span><span class="headingEndMark"> — </span>Infants and children with preexcitation on ECG or documented SVT should be referred to a pediatric cardiologist/electrophysiologist to guide the diagnostic evaluation and to discuss risk assessment and management options. </p><p>Urgent referral is warranted for children who present with SVT associated with any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Syncope</p><p class="bulletIndent1"><span class="glyph">●</span>Heart failure</p><p class="bulletIndent1"><span class="glyph">●</span>Incessant tachycardia</p><p class="bulletIndent1"><span class="glyph">●</span>Other concerning cardiac finding (eg, depressed ventricular function on echocardiogram)</p><p></p><p>For children without any of these concerning findings, initial management should optimally include discussion with a pediatric cardiologist. However, the referral can be done electively on an outpatient basis if there are no urgent concerns. </p><p class="headingAnchor" id="H20"><span class="h2">Electrocardiogram</span><span class="headingEndMark"> — </span>The ECG can help determine the mechanism of tachycardia:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG during SVT</strong> – During SVT, the ECG exhibits a regular rhythm (ie, no variation in the RR interval) with a rate that is usually 220 to 280 beats per minute (bpm) in infants and 180 to 240 bpm in older children  (<a class="graphic graphic_waveform graphicRef77867" href="/d/graphic/77867.html" rel="external">waveform 2</a>). In most cases, the QRS complex is narrow (&lt;80 msec) [<a href="#rid2">2</a>]. An exception is <strong>antidromic</strong> atrioventricular reentrant tachycardia (AVRT), which is associated with a wide complex tachycardia  (<a class="graphic graphic_figure graphicRef50433" href="/d/graphic/50433.html" rel="external">figure 6</a> and <a class="graphic graphic_waveform graphicRef54484" href="/d/graphic/54484.html" rel="external">waveform 3</a>). Antidromic AVRT accounts for &lt;5 percent of cases of pediatric SVT. (See <a class="local">'Orthodromic versus antidromic'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Narrow QRS complex tachycardia</strong> – Orthodromic AVRT and AV nodal reentrant tachycardia (AVNRT) together account for &gt;80 percent of SVTs in childhood. Distinguishing between these two entities can be challenging since both typically have a narrow QRS complex. The following criteria are useful in making this distinction  (<a class="graphic graphic_algorithm graphicRef56048" href="/d/graphic/56048.html" rel="external">algorithm 2</a>) [<a href="#rid39">39</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>When P waves can be discerned, the distance from the R wave of one QRS complex to the P wave following it (RP interval) has diagnostic utility. An RP interval ≥100 msec is more characteristic of AVRT than AVNRT (73 versus 6 percent of cases).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Incessant or nearly incessant SVT with an extremely long RP interval and a P wave axis that is directed superior (negative in leads II, III, and aVF) is seen in permanent junctional reciprocating tachycardia.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>When P waves cannot be discerned, they are usually buried in the QRS complex, which is typical of AVNRT. A P wave that falls just at the end of the QRS complex may distort that complex in such a way as to create a small "pseudo r' wave" in lead V1 or a "pseudo S wave" in the inferior leads. If such terminal r' or S waves are not present during sinus rhythm, their appearance during SVT can be assumed to be diagnostic of AVNRT  (<a class="graphic graphic_figure graphicRef54290" href="/d/graphic/54290.html" rel="external">figure 10</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Wide QRS complex tachycardia</strong> – Wide QRS complex tachycardia should generally prompt consideration of ventricular tachycardia (VT). However, in children, most wide QRS complex tachycardia that occurs with a regular rate represents SVT, not VT. SVT can have a wide QRS complex if the mechanism is antidromic AVRT  (<a class="graphic graphic_figure graphicRef50433" href="/d/graphic/50433.html" rel="external">figure 6</a> and <a class="graphic graphic_waveform graphicRef54484" href="/d/graphic/54484.html" rel="external">waveform 3</a>) or if there is aberrant conduction (eg, functional bundle branch block or "bundle branch aberration") [<a href="#rid2">2,40</a>]. Some patients with orthodromic AVRT begin with wide QRS complexes secondary to bundle branch aberration, which then resolves to a narrow QRS complex tachycardia. (See <a class="local">'Antegrade versus retrograde'</a> above.)</p><p></p><p class="bulletIndent2">In a report of 32 children with wide QRS tachycardia, 7 had orthodromic AVRT with bundle branch aberration, 11 had antidromic AVRT, 8 had atrial flutter with an accessory pathway, and 6 had VT [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent2">The ECG can be helpful in differentiating between VT and SVT. However, making the distinction can be challenging, especially for clinicians unfamiliar with interpreting pediatric ECGs. Consultation with a pediatric cardiologist is generally warranted. The approach to evaluating children with wide QRS complex tachycardia is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children", section on 'Electrocardiography'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG in sinus rhythm</strong> – In sinus rhythm, patients with Wolff-Parkinson-White (WPW) syndrome exhibit preexcitation with a characteristic delta wave, widening of the QRS, and short PR interval  (<a class="graphic graphic_waveform graphicRef75578" href="/d/graphic/75578.html" rel="external">waveform 1</a> and <a class="graphic graphic_waveform graphicRef76226" href="/d/graphic/76226.html" rel="external">waveform 6</a>). The ECG in sinus rhythm is normal in patients with concealed accessory pathways or AVNRT. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Electrocardiographic findings'</a>.)</p><p></p><p class="bulletIndent1">The delta wave is due to slow spread of ventricular activation from the accessory pathway, which precedes normal activation of the ventricle via the AV nodal His-Purkinje system. The accessory pathway can often be localized based on the vector forces of the delta wave. (See  <a class="medical medical_review" href="/d/html/953.html" rel="external">"Anatomy, pathophysiology, and localization of accessory pathways in the preexcitation syndrome", section on 'Localizing the accessory AV connection site based upon the ECG'</a>.)</p><p></p><p class="headingAnchor" id="H21"><span class="h2">Ambulatory monitoring</span><span class="headingEndMark"> — </span>The majority of children with SVT have sporadic brief episodes of tachycardia. Thus, it may be difficult to capture an episode on a standard ECG. Noncontinuous or continuous ECG monitoring may be useful to record episodes of SVT that occur while the child is at home, school, or participating in sports. Ambulatory monitoring helps to establish the frequency and duration of SVT; however, it is less useful in making a diagnosis, since only a few ECG leads are used [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/958.html" rel="external">"Ambulatory ECG monitoring"</a>.)</p><p>Transtelephonic electrocardiographic devices are capable of direct transmission of an ECG as an audio signal by telephone. These devices usually provide limited, noncontinuous sample ECG data for the duration of an event that can be downloaded to the clinician's office for interpretation [<a href="#rid41">41,42</a>].</p><p>Ambulatory (Holter) ECG monitoring allows continuous examination of the patient's rhythm over an extended period of time during ambulatory activity and with physical and psychologic changes. Monitoring is typically recorded from two to three ECG leads and performed for 24 to 48 hours; therefore, it is useful only in patients who have frequent runs of SVT.</p><p>Ambulatory ECG monitoring using an adhesive patch monitor is an alternative to Holter monitoring that allows recordings up to two weeks. In a national registry study of &gt;3000 children who received a 14-day patch monitor, 44 percent of first-detected arrhythmias occurred after 48 hours [<a href="#rid43">43</a>].</p><p>Smartphone applications that can record single-lead ECGs are widely available. Two prospective studies have investigated the utility of these monitors in children and found they can successfully record tracings of diagnostic quality and can differentiate SVT mechanisms in up to 70 percent of patients [<a href="#rid44">44,45</a>].</p><p class="headingAnchor" id="H22"><span class="h2">Exercise testing</span><span class="headingEndMark"> — </span>In children whose symptoms are triggered by exercise, cardiopulmonary exercise testing is sometimes used as a diagnostic modality. Increased adrenergic tone resulting from exertion can sometimes elicit SVT. (See  <a class="medical medical_review" href="/d/html/6473.html" rel="external">"Exercise testing in children and adolescents: Principles and clinical application"</a>.)</p><p>Exercise testing is also used to assess the risk of developing potentially fatal arrhythmias in WPW. In adults, loss of preexcitation at higher heart rates is associated with a decreased risk of sudden death as determined by electrophysiologic (EP) testing. The relationship between loss of preexcitation during exercise and risk of sudden death in children is less certain. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Approach to risk stratification'</a>.)</p><p>Studies in adult patients found that persistence of preexcitation during exercise was found to have a sensitivity of 96 percent for predicting a high-risk EP test and a sensitivity of 80 percent for identifying patients with a history of ventricular fibrillation [<a href="#rid31">31,46</a>].</p><p>Loss of preexcitation in children can be difficult to assess because of the rapidity of AV nodal conduction at young age. A prospective study of 37 children with WPW who underwent exercise testing followed by EP study found a poor correlation between loss of preexcitation and high-risk parameters on EP study, with a sensitivity and specificity of 30 and 71 percent, respectively [<a href="#rid47">47</a>]. In a retrospective study that examined EP data from 208 children with WPW, suppression of the delta wave on exercise testing occurred in 24 patients (12 percent), of whom only 3 were subsequently noted to have a high-risk pathway on EP study [<a href="#rid48">48</a>].</p><p class="headingAnchor" id="H23"><span class="h2">Electrophysiologic evaluation</span><span class="headingEndMark"> — </span>An EP study is often performed as part of the diagnostic evaluation of clinically significant SVT in children. This is especially true if catheter ablation is planned to treat the arrhythmia, although in some cases a diagnostic procedure only may be performed (eg, to evaluate the effect of drug therapy). Indications for EP study for the evaluation of AVRT and AVNRT in children include the following [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mapping the location of an accessory pathway in a patient with AVRT and determining the refractory periods (antegrade and retrograde) of the pathway. This evaluation is often performed before or in conjunction with radiofrequency catheter ablation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inducing and mapping AVNRT before or in conjunction with catheter ablation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determining the mechanism of an unknown type of SVT for the purpose of determining optimum antiarrhythmic drug therapy or performing catheter ablation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determining the mechanism of a wide QRS tachycardia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determining the inducibility and mechanism of an unknown tachycardia in a patient with a congenital heart defect before catheter ablation or surgical intervention.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluating cardiac rhythm during electrical cardioversion or intracardiac overdrive termination of a tachyarrhythmia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determining the presence of arrhythmia in a patient with syncope.</p><p></p><p>A complete EP evaluation requires transvenous catheter electrode insertion and manipulation for pacing and recording. A more limited evaluation may also be made with the use of transesophageal electrodes for pacing and recording [<a href="#rid49">49,50</a>]. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Electrophysiology studies (EPS)'</a>.)</p><p>The details of EP testing are discussed separately. (See  <a class="medical medical_review" href="/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p class="headingAnchor" id="H98069871"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116933.html" rel="external">"Society guideline links: Arrhythmias in children"</a>.)</p><p class="headingAnchor" id="H965681"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Supraventricular tachycardia (SVT) SVT refers to an abnormally rapid heart rhythm originating above the ventricles, often (but not always) with a narrow QRS complex  (<a class="graphic graphic_waveform graphicRef77867" href="/d/graphic/77867.html" rel="external">waveform 2</a>). (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1">The two most common forms of SVT in children are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Atrioventricular reentrant tachycardia (AVRT, including the Wolff-Parkinson-White [WPW] syndrome) (see <a class="local">'AV reentrant tachycardia'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Atrioventricular nodal reentrant tachycardia (AVNRT) (see <a class="local">'AV nodal reentrant tachycardia'</a> above)</p><p></p><p class="bulletIndent1">In this topic review, we use the term "SVT" to refer only to atrioventricular (AV) reciprocating mechanisms (AVRT and AVNRT), excluding primary atrial tachycardias, atrial flutter, and atrial fibrillation. Atrial tachycardias are discussed separately. (See  <a class="medical medical_review" href="/d/html/14407.html" rel="external">"Atrial tachyarrhythmias in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – SVT is the most common rhythm disturbance in children. Most patients with SVT have structurally normal hearts; however, children with congenital heart disease are at the greatest risk for SVT. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanism</strong> – Both AVRT and AVNRT are reentrant rhythms (two distinct pathways for conduction with unidirectional block in one of the two pathways), which allows an electrical impulse to cycle repetitively, resulting in rapid and regular ventricular contractions. AVRT is particularly common during infancy, while AVNRT is more common after two years of age. (See <a class="local">'Mechanisms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs and symptoms</strong> – Signs and symptoms of SVT vary according to age. In infants, symptoms of SVT may include pallor, fussiness, irritability, poor feeding, and/or cyanosis. If tachycardia goes unrecognized for a long period of time, symptoms of heart failure (eg, tachypnea, fatigue with feeding, poor weight gain) can develop. Common symptoms of SVT in children and adolescents include palpitations, chest discomfort, fatigue, and lightheadedness. Syncope is less common and may be a warning sign for increased risk of sudden death. (See <a class="local">'Signs and symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of SVT is based chiefly on the ECG findings. Ambulatory monitoring can help establish the frequency and duration of SVT. Infants and children with preexcitation on ECG or documented SVT should be referred for evaluation by a pediatric cardiologist. Electrophysiologic testing is often performed as part of the diagnostic evaluation of clinically significant SVT in children, particularly if catheter ablation is planned. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ECG during SVT</strong> – Episodes of SVT are usually paroxysmal and characterized by abrupt onset and termination. The average duration is 10 to 15 minutes. During SVT, the ECG exhibits a regular rhythm (ie, no variation in the RR interval) with a rate that is usually 220 to 280 beats per minute (bpm) in infants and 180 to 240 bpm in older children  (<a class="graphic graphic_waveform graphicRef77867" href="/d/graphic/77867.html" rel="external">waveform 2</a>). In most cases, the QRS complex is narrow (&lt;80 msec). Wide QRS complex tachycardia occurs in antidromic AVRT  (<a class="graphic graphic_figure graphicRef50433" href="/d/graphic/50433.html" rel="external">figure 6</a> and <a class="graphic graphic_waveform graphicRef54484" href="/d/graphic/54484.html" rel="external">waveform 3</a>) and occasionally in other reentrant tachycardias with aberrant conduction (eg, functional bundle branch block or "bundle branch aberration"). (See <a class="local">'Electrocardiogram'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ECG in sinus rhythm</strong> – In sinus rhythm, patients with WPW exhibit preexcitation with a characteristic delta wave, widening of the QRS, and short PR interval  (<a class="graphic graphic_waveform graphicRef75578" href="/d/graphic/75578.html" rel="external">waveform 1</a> and <a class="graphic graphic_waveform graphicRef76226" href="/d/graphic/76226.html" rel="external">waveform 6</a>). The ECG in sinus rhythm is normal in patients with concealed accessory pathways or AVNRT. (See <a class="local">'Electrocardiogram'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural history</strong> – For patients who present with SVT in early infancy, symptoms often resolve by one year of age and long-term therapy may not be needed; however, some patients may have recurrence later in childhood. By contrast, SVT tends to persist in children who present after the age of five years. (See <a class="local">'Natural history'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin 1990; 8:411.</a></li><li class="breakAll">Perry JC. Supraventricular tachycardia. In: Science and Practice of Pediatric Cardiology, 2nd, Garson A Jr, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.2059.</li><li><a class="nounderline abstract_t">Tripathi A, Black GB, Park YM, Jerrell JM. Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort. Pediatr Cardiol 2014; 35:368.</a></li><li><a class="nounderline abstract_t">Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992; 69:1028.</a></li><li><a class="nounderline abstract_t">Tanel RE, Walsh EP, Triedman JK, et al. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr 1997; 131:878.</a></li><li><a class="nounderline abstract_t">Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996; 131:66.</a></li><li><a class="nounderline abstract_t">Krahn AD, Manfreda J, Tate RB, et al. The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study. Ann Intern Med 1992; 116:456.</a></li><li><a class="nounderline abstract_t">Sano S, Komori S, Amano T, et al. Prevalence of ventricular preexcitation in Japanese schoolchildren. Heart 1998; 79:374.</a></li><li><a class="nounderline abstract_t">Perry JC, Garson A Jr. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990; 16:1215.</a></li><li><a class="nounderline abstract_t">Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985; 5:130.</a></li><li><a class="nounderline abstract_t">Giuliani ER, Fuster V, Brandenburg RO, Mair DD. Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve. Mayo Clin Proc 1979; 54:163.</a></li><li><a class="nounderline abstract_t">Smith WM, Gallagher JJ, Kerr CR, et al. The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein's anomaly of the tricuspid valve. Am J Cardiol 1982; 49:1223.</a></li><li><a class="nounderline abstract_t">Kugler JD, Danford DA, Deal BJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994; 330:1481.</a></li><li><a class="nounderline abstract_t">Dorostkar PC, Silka MJ, Morady F, Dick M 2nd. Clinical course of persistent junctional reciprocating tachycardia. J Am Coll Cardiol 1999; 33:366.</a></li><li><a class="nounderline abstract_t">Wren C. Incessant tachycardias. Eur Heart J 1998; 19 Suppl E:E32.</a></li><li><a class="nounderline abstract_t">Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 1990; 16:739.</a></li><li><a class="nounderline abstract_t">Sung RJ, Waxman HL, Saksena S, Juma Z. Sequence of retrograde atrial activation in patients with dual atrioventricular nodal pathways. Circulation 1981; 64:1059.</a></li><li><a class="nounderline abstract_t">McGuire MA, Bourke JP, Robotin MC, et al. High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation 1993; 88:2315.</a></li><li><a class="nounderline abstract_t">Van Hare GF, Chiesa NA, Campbell RM, et al. Atrioventricular nodal reentrant tachycardia in children: effect of slow pathway ablation on fast pathway function. J Cardiovasc Electrophysiol 2002; 13:203.</a></li><li><a class="nounderline abstract_t">Kugler JD, Danford DA. Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996; 129:324.</a></li><li><a class="nounderline abstract_t">Silka MJ, Kron J, Halperin BD, McAnulty JH. Mechanisms of AV node reentrant tachycardia in young patients with and without dual AV node physiology. Pacing Clin Electrophysiol 1994; 17:2129.</a></li><li><a class="nounderline abstract_t">Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr 2008; 97:1035.</a></li><li><a class="nounderline abstract_t">Cain N, Irving C, Webber S, et al. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 2013; 112:961.</a></li><li><a class="nounderline abstract_t">Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981; 98:875.</a></li><li><a class="nounderline abstract_t">Paul T, Guccione P, Garson A Jr. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation. Am J Cardiol 1990; 65:318.</a></li><li><a class="nounderline abstract_t">Harahsheh A, Du W, Singh H, Karpawich PP. Risk factors for atrioventricular tachycardia degenerating to atrial flutter/fibrillation in the young with Wolff-Parkinson-White. Pacing Clin Electrophysiol 2008; 31:1307.</a></li><li><a class="nounderline abstract_t">Friedman RA, Walsh EP, Silka MJ, et al. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 2002; 25:1000.</a></li><li><a class="nounderline abstract_t">Obeyesekere MN, Leong-Sit P, Massel D, et al. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation 2012; 125:2308.</a></li><li><a class="nounderline abstract_t">Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1996; 27:690.</a></li><li><a class="nounderline abstract_t">Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301:1080.</a></li><li><a class="nounderline abstract_t">Sharma AD, Yee R, Guiraudon G, Klein GJ. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987; 10:373.</a></li><li><a class="nounderline abstract_t">Munger TM, Packer DL, Hammill SC, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993; 87:866.</a></li><li><a class="nounderline abstract_t">Klein GJ, Prystowsky EN, Yee R, et al. Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation 1989; 80:1902.</a></li><li><a class="nounderline abstract_t">Dubin AM, Collins KK, Chiesa N, et al. Use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome. Cardiol Young 2002; 12:248.</a></li><li><a class="nounderline abstract_t">Etheridge SP, Escudero CA, Blaufox AD, et al. Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study. JACC Clin Electrophysiol 2018; 4:433.</a></li><li><a class="nounderline abstract_t">Lundberg A. Paroxysmal atrial tachycardia in infancy: long-term follow-up study of 49 subjects. Pediatrics 1982; 70:638.</a></li><li><a class="nounderline abstract_t">Benson DW Jr, Dunnigan A, Benditt DG. Follow-up evaluation of infant paroxysmal atrial tachycardia: transesophageal study. Circulation 1987; 75:542.</a></li><li><a class="nounderline abstract_t">Cohen MI, Wieand TS, Rhodes LA, Vetter VL. Electrophysiologic properties of the atrioventricular node in pediatric patients. J Am Coll Cardiol 1997; 29:403.</a></li><li><a class="nounderline abstract_t">Jaeggi ET, Gilljam T, Bauersfeld U, et al. Electrocardiographic differentiation of typical atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway in children. Am J Cardiol 2003; 91:1084.</a></li><li><a class="nounderline abstract_t">Benson DW Jr, Smith WM, Dunnigan A, et al. Mechanisms of regular, wide QRS tachycardia in infants and children. Am J Cardiol 1982; 49:1778.</a></li><li><a class="nounderline abstract_t">Yaari J, Gruber D, Blaufox AD. Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants. J Pediatr 2018; 193:109.</a></li><li><a class="nounderline abstract_t">Saarel EV, Stefanelli CB, Fischbach PS, et al. Transtelephonic electrocardiographic monitors for evaluation of children and adolescents with suspected arrhythmias. Pediatrics 2004; 113:248.</a></li><li><a class="nounderline abstract_t">Bolourchi M, Batra AS. Diagnostic yield of patch ambulatory electrocardiogram monitoring in children (from a national registry). Am J Cardiol 2015; 115:630.</a></li><li><a class="nounderline abstract_t">Ferdman DJ, Liberman L, Silver ES. A Smartphone Application to Diagnose the Mechanism of Pediatric Supraventricular Tachycardia. Pediatr Cardiol 2015; 36:1452.</a></li><li><a class="nounderline abstract_t">Nguyen HH, Van Hare GF, Rudokas M, et al. SPEAR Trial: Smartphone Pediatric ElectrocARdiogram Trial. PLoS One 2015; 10:e0136256.</a></li><li><a class="nounderline abstract_t">Gaita F, Giustetto C, Riccardi R, et al. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol 1989; 64:487.</a></li><li><a class="nounderline abstract_t">Dalili M, Vahidshahi K, Aarabi-Moghaddam MY, et al. Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value? Pediatr Cardiol 2014; 35:1142.</a></li><li><a class="nounderline abstract_t">Mah DY, Sherwin ED, Alexander ME, et al. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol 2013; 36:1117.</a></li><li><a class="nounderline abstract_t">Kesek M, Sheikh H, Bastani H, et al. The sensitivity of transesophageal pacing for screening in atrial tachycardias. Int J Cardiol 2000; 72:239.</a></li><li><a class="nounderline abstract_t">Volkmann H, Kühnert H, Dannberg G. Electrophysiological evaluation of tachycardias using transesophageal pacing and recording. Pacing Clin Electrophysiol 1990; 13:2044.</a></li></ol></div><div id="topicVersionRevision">Topic 5783 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2205383" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Differential diagnosis of supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2205383" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Differential diagnosis of supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23996086" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1561973" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Supraventricular tachycardia mechanisms and their age distribution in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9427894" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8554021" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1739235" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9616346" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence of ventricular preexcitation in Japanese schoolchildren.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2229769" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3964800" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/431122" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7064845" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein's anomaly of the tricuspid valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8164700" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9973016" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical course of persistent junctional reciprocating tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9717022" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Incessant tachycardias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2387945" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7285296" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Sequence of retrograde atrial activation in patients with dual atrioventricular nodal pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8222125" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11942583" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Atrioventricular nodal reentrant tachycardia in children: effect of slow pathway ablation on fast pathway function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8804320" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7845830" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mechanisms of AV node reentrant tachycardia in young patients with and without dual AV node physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18489621" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23827401" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7229788" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2301260" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18811812" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Risk factors for atrioventricular tachycardia degenerating to atrial flutter/fibrillation in the young with Wolff-Parkinson-White.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12137336" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22532593" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8606283" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/492252" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Ventricular fibrillation in the Wolff-Parkinson-White syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3598007" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8443907" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2486558" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Asymptomatic Wolff-Parkinson-White. Should we intervene?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12365171" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30067481" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7122164" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Paroxysmal atrial tachycardia in infancy: long-term follow-up study of 49 subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3815766" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Follow-up evaluation of infant paroxysmal atrial tachycardia: transesophageal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9014996" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Electrophysiologic properties of the atrioventricular node in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12714151" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Electrocardiographic differentiation of typical atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7081063" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Mechanisms of regular, wide QRS tachycardia in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29198533" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14754934" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Transtelephonic electrocardiographic monitors for evaluation of children and adolescents with suspected arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25591894" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Diagnostic yield of patch ambulatory electrocardiogram monitoring in children (from a national registry).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25958154" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A Smartphone Application to Diagnose the Mechanism of Pediatric Supraventricular Tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26295569" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : SPEAR Trial: Smartphone Pediatric ElectrocARdiogram Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2773792" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24728424" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23617412" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10716133" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The sensitivity of transesophageal pacing for screening in atrial tachycardias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1704590" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Electrophysiological evaluation of tachycardias using transesophageal pacing and recording.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
